The DIPPER Study presentation discusses the SafeBreak Vascular randomized controlled trial data.
*Approved by AVA for 1-hour of CE credit
Objectives:
Separation Device (FASD) is installed in a PIV line, the process
for replacing a FASD, and how a FASD functions.
that detail the impact that a FASD can have on mechanical PIV
complication rates and delays in therapy.
Speaker Bio:
Vance Clement, CEO of Lineus Medical
Vance has over 25 years of experience in the medical device space. He started with Lineus Medical in 2015 as Chief Operating Officer. He served as Vice President of Sales and Marketing at BlueInGreen, a developer and manufacturer of capital equipment for water treatment. Under his leadership, BlueInGreen more than quadrupled its sales in one year. Prior to BlueInGreen, Vance was Sr. Director of Marketing and a key player in Mako Surgical’s growth from an orthopedic start-up with 17 installed surgical robots to over 156 installed robots and sales of over $100M. He was the developer of Mako’s strategic plan and the chief architect of Mako’s Total Hip Arthroplasty application. Vance spent ten years working for Smith & Nephew Orthopaedics in various senior marketing and sales roles, including a 2.5 year European assignment in Brussels, Belgium. Vance began his career at Wright Medical Technology (now Microport) in manufacturing as an industrial engineer and later moved into product management. Vance earned a Bachelor’s of Science in Industrial Engineering from the University of Arkansas and an MBA from Christian Brothers University in Memphis, TN.